FAQ

General Report & Navigation

What is included in the dsm-firmenich 2025 Integrated Annual Report?

The 2025 Integrated Annual Report provides a comprehensive overview of our company’s performance, strategy, and governance. It includes sections on:

• Our Company: our strategy, business model, and value creation

• Our Businesses: an overview of each of our Business Units, their year in review, market performance and actions on Sustainability, Innovations and Partnerships

• Our Performance: our financial results and sustainability activities

• Governance, Risk Management and Business Ethics: Corporate governance, oard oversight, biographies of our BoD and ExCo, and our approach to risk and business ethics

• Compensation: a comprehensive report of our remuneration

• Sustainability Statements: our strategy, targets, metrics, and results

• Consolidated Financial Statements and Parent Company Financial Statements: detailed financial disclosures for 2025

• Other Information: additional 5-year summary of financials and sustainability information, plus concepts, ratios and abbreviations

The Report integrates financial and non-financial performance into a single, cohesive narrative.

How do I navigate the online annual Report?

The online Report is structured around clearly defined main sections accessible through the primary navigation menu. Each section contains sub-sections with anchors and cross-links to related content. Users can seamlessly move between strategy, performance, sustainability, and financial disclosures, with consistent navigation tools and search functionality to quickly locate specific topics.

Where can I download a PDF version of the 2025 report?

A full, downloadable PDF of our 2025 Integrated Annual Report is available in the Downloads section of this website. Users can access the complete Report in a single PDF file, along with selected standalone documents such as the financial statements or sustainability disclosures, where applicable.

Financial Performance & Results

What were the key financial highlights for 2025?

• € 9,034 million Sales from continuing operations (0% versus 2024)

• € 12,521 million Sales total Group (-2% versus 2024)

• € 1,772 million Adjusted EBITDA from continuing operations (+1% versus 2024)

• € 2,279 million Adjusted EBITDA total Group (+8% versus 2024)

• € 950 million Adjusted gross operating free cash flow from continuing operations, versus €1,217 million in 2024

These results reflect improved operational performance, margin expansion, and strong cash generation.

Where can I find the full financial statements (income statement, balance sheet, and cash flow statement)?

The full consolidated financial statements are available in both the Consolidated Financial Statements and Parent Company Financial Statements sections of the Report. This section includes the consolidated income statement, balance sheet, cash flow statement, statement of changes in equity, and detailed notes.

Strategy & Business Model

What is dsm-firmenich’s strategy going forward?

Our Strategy was first outlined by our CEO, Dimitri de Vreeze, at our Capital Markets Day presentation in 2024. The dream was to build a new and unique company that would not just compete in the market but redefine it. In 2025, we continued to execute that five-phase strategy (dream, merge, focus, tune and accelerate) making progress in innovation, in how we serve our customers, in unlocking synergies, and in building a stronger and more connected company.

What are the company’s long-term targets and outlook for 2026 and beyond?

We aim to deliver continued organic growth, further margin expansion, and strong cash generation over the medium term. We are focused on achieving our financial ambitions while strengthening our innovation pipeline, enhancing competitiveness, and delivering long-term shareholder value.

What are the key Business Units, and what do they do?

The company operates through three core business units:

• Perfumery & Beauty (P&B): P&B is a leading creation and innovation partner for the most iconic global and local brands in consumer goods, lifestyle, and luxury beauty.

• Taste, Texture & Health (TTH): TTH tackles some of society’s biggest challenges: providing nutritious, healthy and sustainable food and beverages, and accelerating the diet transformation with appealing taste and texture, and nourishing a growing global population while minimizing food loss and waste.

• Health, Nutrition & Care (HNC): HNC supports the health of the world’s growing population by delivering a range of innovative nutrition and care solutions. It serves the early life nutrition, dietary supplements, pharmaceutical, medical nutrition, and biomedical materials markets, as well as the nutrition improvement sector.

Innovation

What were the major innovations in 2025?

In 2025, key innovations included:

• Amberever®neo, a new captive ingredient for exclusive use by our perfumers;

• Mixiren®EVO, a next-generation coagulant for cheese production, improving yield and process efficiency.

• GLYCARE® HMO 2FL, an expansion of our human milk oligosaccharide (HMO) portfolio for early-life nutrition.

• emotiOn™ social connection, a first-of-its-kind fragrance innovation designed to boost social bravery and spark human connections.

• life’s®OMEGA O2722: our single-source algal omega-3 has the same EPA to DHA ratio naturally found in standard fish oil, but with twice the potency. It was launched after meeting stringent Chinese regulations

Sustainability

How does dsm-firmenich approach sustainability?

Sustainability is fully embedded in our business model – not only in how we operate, but also in how we design and deliver products and services. By actively addressing key consumer demands in areas such as preventative health, healthier diets, and wellbeing, we are creating long-term value for our stakeholders while contributing to a healthier planet.

What is the dsm-firmenich sustainability program?

Our Sustainability program starts with our company’s purpose of bringing progress to life, identifies eight key focus areas, sets a series of time-bound and quantifiable targets for each, and then translates achieving them into a series of actions for our Business Units. Our focus areas are

• Promote human rights and needs

• Fuel healthy lives

• Nurture wellbeing

• Foster a responsible supply chain

• Design sustainable products

• Accelerate climate action

• Safeguard nature and biodiversity

• Conserving our planet’s resources

Where can I find ESG metrics and performance data?

Detailed ESG metrics, targets, and performance indicators are available in the Sustainability Statements section of the Report. This includes environmental, social, and governance data tables, as well as progress against stated commitments.

Does dsm-firmenich disclose climate and emissions data?

Yes. In line with the EU’s Corporate Sustainability Reporting Directive and other recognized disclosure frameworks and standards, our Scope 1, Scope 2 & Scope 3 greenhouse gas emissions, along with climate-related risks and mitigation actions, are included.

Governance & Risk

Who are the members of the Board of Directors and Executive Committee?

The composition, biographies, and roles of the Board of Directors and Executive Committee are detailed in the Governance section of the Report, including Committee memberships.

What are our main risks, and how are they managed?

The top risks facing the company are described in the Material risks and uncertainties section.

Where can shareholders find dividend and share performance information?

Information on dividends, dividend proposals, historical payments, share performance, and any share buyback initiatives is provided in the Dividend and share price section of the Report.

General Queries & Definitions

What do the financial and non-financial terms in the Report mean?

Definitions and explanations of financial terminology and non-financial performance measures are provided in the Concepts and ratios section. This includes reconciliations and calculation methodologies where applicable.

When did dsm-firmenich announce the divestment of Animal Health & Nutrition?

In February 2024, we announced our intention to separate ANH from the company, having concluded that its full potential could best be realized under a different ownership structure. In the first stage, completed on June 2, 2025, we sold our 50% stake in the Feed Enzymes Alliance to our partner Novonesis, a global leader in biosolutions. In the second stage, announced on February 9, 2026, we agreed to sell our remaining ANH business to CVC Capital Partners.